Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Koru Medical Systems Inc (KRMD)

Koru Medical Systems Inc (KRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 97,819
  • Shares Outstanding, K 45,710
  • Annual Sales, $ 28,520 K
  • Annual Income, $ -13,740 K
  • 60-Month Beta 0.53
  • Price/Sales 3.41
  • Price/Cash Flow N/A
  • Price/Book 4.67
Trade KRMD with:

Options Overview Details

View History
  • Implied Volatility 213.14% ( -329.93%)
  • Historical Volatility 65.37%
  • IV Percentile 69%
  • IV Rank 36.29%
  • IV High 543.07% on 04/22/24
  • IV Low 25.22% on 07/13/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 164
  • Open Int (30-Day) 162

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate -0.03
  • Low Estimate -0.04
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.05 +7.32%
on 04/19/24
2.71 -18.68%
on 04/05/24
+0.10 (+4.76%)
since 03/22/24
3-Month
1.98 +11.21%
on 02/01/24
2.71 -18.68%
on 04/05/24
+0.09 (+4.27%)
since 01/24/24
52-Week
1.98 +11.21%
on 02/01/24
4.48 -50.89%
on 04/28/23
-1.90 (-46.34%)
since 04/24/23

Most Recent Stories

More News
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of -25% and 1%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

KRMD : 2.20 (+2.80%)
HTGM : 0.4800 (-20.00%)
KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use...

KRMD : 2.20 (+2.80%)
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use...

KRMD : 2.20 (+2.80%)
KORU Medical Systems Inc. (KRMD) Reports Q4 Loss, Misses Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 20% and 1.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

KRMD : 2.20 (+2.80%)
ANGO : 5.87 (-2.65%)
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use...

KRMD : 2.20 (+2.80%)
Paragon 28, Inc. (FNA) Reports Q4 Loss, Tops Revenue Estimates

Paragon 28, Inc. (FNA) delivered earnings and revenue surprises of -466.67% and 2.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

FNA : 9.64 (-4.08%)
KRMD : 2.20 (+2.80%)
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -10% and 0.23%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ATEC : 12.74 (-1.47%)
KRMD : 2.20 (+2.80%)
Penumbra (PEN) Q4 Earnings and Revenues Surpass Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 14.29% and 1.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

PEN : 206.15 (+0.22%)
KRMD : 2.20 (+2.80%)
KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use...

KRMD : 2.20 (+2.80%)
Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Lag Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -34.62% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

SRTS : 3.28 (-3.53%)
KRMD : 2.20 (+2.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Repro-Med Systems Inc. is engaged in the design and manufacture of medical devices directing resources to the global markets for emergency medical products and infusion therapy.

See More

Key Turning Points

3rd Resistance Point 2.41
2nd Resistance Point 2.34
1st Resistance Point 2.27
Last Price 2.20
1st Support Level 2.13
2nd Support Level 2.06
3rd Support Level 1.99

See More

52-Week High 4.48
Fibonacci 61.8% 3.52
Fibonacci 50% 3.23
Fibonacci 38.2% 2.93
Last Price 2.20
52-Week Low 1.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar